CHAD THERAPEUTICS INC (CTU) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 158 transactions totaling $110.5K, demonstrating a bearish sentiment with -$50.9K in net insider flow. The most recent transaction on Jul 9, 2008 involved a transaction of 62,618 shares valued at $11.9K.
No significant insider buying has been recorded for CTU in the recent period.
No significant insider selling has been recorded for CTU in the recent period.
Based on recent SEC filings, insider sentiment for CTU is bearish with an Insider Alignment Score of 27/100 and a net flow of -$50.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CHAD THERAPEUTICS INC (CTU) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading CTU stock, having executed 158 transactions in the past 90 days. The most active insider is Earl L. Yager (Executive), who has made 25 transactions totaling $72.9K.
Get notified when executives and directors at CTU file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 9, 2008 | T. Wolfstein Philip | Executive | Other | 62,618 | $0.19 | $11.9K | |
| Mar 28, 2008 | A. Kern Tracy | Executive | Award | 286 | $0.46 | $132 | |
| Mar 8, 2008 | A. Kern Tracy | Executive | Award | 439 | $0.38 | $167 | |
| Feb 8, 2008 | E. Jones Thomas | Executive | Award | 741 | $0.44 | $326 | |
| Feb 8, 2008 | A. Kern Tracy | Executive | Disposition | 16 | $0.40 | $6 | |
| Feb 8, 2008 | Mcculloh Kevin | Executive | Disposition | 287 | $0.40 | $115 | |
| Feb 8, 2008 | L. Yager Earl | Executive | Award | 1,111 | $0.44 | $489 | |
| Feb 1, 2008 | A. Kern Tracy | Executive | Award | 308 | $0.55 | $169 | |
| Jan 4, 2008 | A. Kern Tracy | Executive | Award | 4 | $0.44 | $2 | |
| Dec 26, 2007 | A. Kern Tracy | Executive | Award | 547 | $0.31 | $170 | |
| Dec 3, 2007 | A. Kern Tracy | Executive | Award | 21 | $0.44 | $9 | |
| Nov 30, 2007 | A. Kern Tracy | Executive | Award | 366 | $0.44 | $161 | |
| Nov 1, 2007 | L. Yager Earl | Executive | Award | 1 | $0.66 | $1 | |
| Oct 31, 2007 | A. Kern Tracy | Executive | Award | 322 | $0.73 | $235 | |
| Oct 1, 2007 | Alfonso Del Toro | Executive | Award | 2,752 | $0.80 | $2.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Discretionary(I) | 104 | $149.7K | 49.0% |
Sale(S) | 8 | $80.7K | 26.4% |
Award(A) | 36 | $31.5K | 10.3% |
Purchase(P) | 6 | $29.8K | 9.7% |
Other(J) | 1 | $11.9K | 3.9% |
Disposition(D) | 3 | $2.1K | 0.7% |
Insider selling pressure at CHAD THERAPEUTICS INC has increased, with 9 insiders executing 158 transactions across all time. Total sales of $80.7K significantly outpace purchases of $29.8K, resulting in a net outflow of $50.9K. This selling activity appears largely discretionary, which may warrant closer attention from investors.